NUVL
Price
$123.94
Change
+$0.04 (+0.03%)
Updated
Jul 13 closing price
Capitalization
9.81B
24 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$14.96
Change
-$0.89 (-5.62%)
Updated
Jul 13 closing price
Capitalization
1.11B
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NUVL vs XNCR

NUVL vs XNCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NUVL vs. XNCR commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVL is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (NUVL: $123.90 vs. XNCR: $14.96)
Brand notoriety: NUVL and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVL: 41% vs. XNCR: 46%
Market capitalization -- NUVL: $9.81B vs. XNCR: $1.11B
NUVL [@Biotechnology] is valued at $9.81B. XNCR’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVL’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • NUVL’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both NUVL and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVL’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • NUVL’s TA Score: 5 bullish, 5 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NUVL and XNCR are a good buy in the short-term.

Price Growth

NUVL (@Biotechnology) experienced а +0.14% price change this week, while XNCR (@Biotechnology) price change was +0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.13%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +1806.57%.

Reported Earning Dates

NUVL is expected to report earnings on Aug 06, 2026.

XNCR is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (-3.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($9.81B) has a higher market cap than XNCR($1.11B). NUVL YTD gains are higher at: 23.213 vs. XNCR (-2.286). XNCR has higher annual earnings (EBITDA): -131.66M vs. NUVL (-438.9M). NUVL has more cash in the bank: 1.29B vs. XNCR (445M). XNCR has higher revenues than NUVL: XNCR (97.4M) vs NUVL (0).
NUVLXNCRNUVL / XNCR
Capitalization9.81B1.11B884%
EBITDA-438.9M-131.66M333%
Gain YTD23.213-2.286-1,015%
P/E RatioN/AN/A-
Revenue097.4M-
Total Cash1.29B445M289%
Total DebtN/A175M-
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUVLXNCR
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 18 days ago
74%
Declines
ODDS (%)
Bearish Trend 18 days ago
78%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
NUVL
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EHSTX30.69N/A
N/A
Eaton Vance Large-Cap Value A
TBCUX17.86N/A
N/A
Tweedy, Browne Intl Val II - Ccy UnH
AIVOX12.88N/A
N/A
American Century International Opps A
SWLGX18.42N/A
N/A
Schwab ® US Large-Cap Growth Idx
CICAX67.69-0.76
-1.11%
American Funds Invmt Co of Amer 529-A

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with MLTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+0.03%
MLTX - NUVL
49%
Loosely correlated
+0.25%
XNCR - NUVL
42%
Loosely correlated
-5.62%
PCVX - NUVL
41%
Loosely correlated
-2.03%
PTGX - NUVL
39%
Loosely correlated
-1.16%
GOSS - NUVL
39%
Loosely correlated
-15.09%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-5.62%
VCYT - XNCR
52%
Loosely correlated
+0.90%
KURA - XNCR
52%
Loosely correlated
-4.72%
RCUS - XNCR
49%
Loosely correlated
-2.94%
VIR - XNCR
49%
Loosely correlated
-2.41%
MLTX - XNCR
49%
Loosely correlated
+0.25%
More